熱門資訊> 正文

Enveric Biosciences GAAP每股收益为-6.12美元

2026-03-30 16:33

Enveric Biosciences, Inc.(ENVB) 0

Enveric Biosciences press release (ENVB): Q4 GAAP EPS of -$6.12.
The company had cash-on-hand of $4.7 million for the quarter ended December 31, 2025. For the year ended December 31, 2025, the Company raised gross proceeds, through offerings, of $12.2 million.

More on Enveric Biosciences

Enveric rises as Gilgamesh drops patent petition
Enveric Biosciences announces $1.5M registered direct offering, warrant placement; shares down
Financial information for Enveric Biosciences

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。